TULA EP2BRecalls & reported problems
Smith & Nephew, Inc. · TULA EARPLUG 10-PACK -SIZE 2 · Class 3
All models of TULA (9)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00840128600085), received between Aug 9, 2022 and Aug 9, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash1
Patient problems
- Insufficient Information1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 9, 2022Leak/Splash; Leak/Splash
IT WAS REPORTED THAT, DURING TULA PROCEDURE, THE PATIENT WAS FITTED WITH SIZE 2 EARPLUG IN ONE EAR, THE EAR WAS FILLED APPROPRIATELY, AND THE CONTROL UNIT DISPLAYED AN ALERT WHEN THE HCP ATTEMPTED TO INITIATE IONTOPHORESIS. IT WAS DETERMINED THAT THE HCP HAD ATTEMPTED TO START THE CHANNEL THAT WAS NOT YET CONNECTED; WHEN THEY PRESSED THE CORRECT CHANNEL, IONTOPHORESIS INITIATED APPROPRIATELY. THE SURGEON THEN ATTEMPTED TO PLACE THE SECOND EARSET USING A SIZE 2 EARPLUG, DETERMINED THAT IT WAS TOO SMALL AND CHANGED TO A SIZE 3 EARPLUG. THEN, THE EAR WAS FILLED AND IONTOPHORESIS INITIATED. DURING IONTOPHORESIS, THE PATIENT WAS MOVING SIGNIFICANTLY; BOTH THE PARENTS AND MULTIPLE HCPS ATTEMPTED TO RESTRAIN THE PATIENT MOVEMENT. THE EARSETS WERE DISLODGED MULTIPLE TIMES LEADING TO ALERTS ON THE CONTROL UNIT. THE ALERTS MAY ALSO HAVE BEEN DUE TO LEAKS. THE PATIENT WAS NOT ABLE TO BE DISTRACTED WITH BEHAVIOR MANAGEMENT TECHNIQUES. THE CASE WAS ABORTED. AFTER THE PATIENT LEFT, THE NP STATED THAT THEY JUST COULDN'T GET THE EARSETS/EARPLUGS TO STAY IN. LATER THAT EVENING, THE SURGEON COMMUNICATED THAT HE HAD INVESTIGATED THE EARSETS AFTER THE PROCEDURE. HE STATED HIS OPINION THAT THE EARSET V
Patient problems: Insufficient Information
MAUDE report 15195699 ↗
Other Tympanostomy tube delivery product with drug devices
- TULA 72290090Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug7 reports
- TULA TDS114GSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug5 reports
- TULA TULAKIT2Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug4 reports
- TULA TYMB001Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug4 reports
- TULA 72290097Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug3 reports
- TULA IOCNTRLSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug2 reports
- TULA 72290098Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug2 reports
- TULA EP1PSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page